<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896911420257</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896911420257</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>G-CSF-Producing Malignant Pleural Mesothelioma</article-title>
<subtitle>An Autopsy Case Report With Literature Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Oka</surname><given-names>Kuniyuki</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911420257">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sarashina</surname><given-names>Gen</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911420257">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yonekawa</surname><given-names>Nobuo</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896911420257">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Watanabe</surname><given-names>Osamu</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911420257">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Miyao</surname><given-names>Yoshiko</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911420257">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hashimoto</surname><given-names>Toshio</given-names></name>
<xref ref-type="aff" rid="aff1-1066896911420257">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yatabe</surname><given-names>Yasushi</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1066896911420257">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896911420257"><label>1</label>Mito Saiseikai General Hospital, Mito, Ibaraki, Japan</aff>
<aff id="aff2-1066896911420257"><label>2</label>Aichi Cancer Center, Nagoya, Japan</aff>
<author-notes>
<corresp id="corresp1-1066896911420257">Kuniyuki Oka, Department of Pathology, Mito Saiseikai General Hospital, 3-3-10 Futabadai, Mito, Ibaraki 311-4198, Japan Email: <email>oka-k@gb3.so-net.ne.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>3</issue>
<fpage>272</fpage>
<lpage>275</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>This study reports a 54-year-old man who was a carpenter by occupation. He suffered from left chest and back pain and left pleural effusion. Peripheral blood showed granulocytosis and high serum titers of granulocyte–colony stimulating factor (G-CSF) and CYFRA. He died 20 months later. At autopsy, a pleural tumor located around the left lung and thickening of the pericardium, diaphragm, and esophagus by tumor infiltration was seen. The tumor proliferated in papillary and solid alveolar patterns by neoplastic cells. They were positive for calretinin, D2-40, CK5/6, HBME-1, G-CSF, CK19, and E-cadherin. He was diagnosed with G-CSF-producing epithelioid malignant pleural mesothelioma.</p>
</abstract>
<kwd-group>
<kwd>malignant pleural mesothelioma</kwd>
<kwd>granulocyte–colony stimulating factor (G-CSF)</kwd>
<kwd>granulocytosis</kwd>
<kwd>autopsy case</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896911420257" sec-type="intro">
<title>Introduction</title>
<p>Epithelioid malignant pleural mesothelioma (MPM) consists of cuboidal, columnar, or flattened cells forming tubular or papillary structures resembled adenocarcinoma and may be difficult to differentiate from pulmonary adenocarcinoma: pseudomesotheliomatous adenocarcinoma of the lung (PMAL). We have earlier reported 3 cases that were initially diagnosed as an MPM but finally diagnosed as a PMAL.<sup><xref ref-type="bibr" rid="bibr1-1066896911420257">1</xref></sup> Features that favor malignant mesothelioma (MM) include (<italic>a</italic>) positive staining for acid mucopolysaccharide; (<italic>b</italic>) lack of carcinoembryonic antigen (CEA); (<italic>c</italic>) strong staining for keratin; (<italic>d</italic>) positive for calretinin, WT1, cytokeratin (CK) 5/6, mesothelin, and thrombomodulin; and (5) the presence of long microvilli and abundant tonofilaments on electron microscopy.<sup><xref ref-type="bibr" rid="bibr2-1066896911420257">2</xref></sup> Granulocyte–colony stimulating factor (G-CSF)-producing carcinomas arising in several organs, especially in the lung, stomach, liver, thyroid gland, gall bladder, urinary bladder, thymus, and cervix, have been described. Most G-CSF-producing carcinomas are poorly differentiated or undifferentiated and have a poor prognosis. We have earlier reported a G-CSF-producing spindle cell carcinoma case arising in the pharynx.<sup><xref ref-type="bibr" rid="bibr3-1066896911420257">3</xref></sup></p>
<p>We report here the case of a 54-year-old man who was initially diagnosed with MPM or PMAL at core needle biopsy and who died 20 months after the initial symptoms appeared. He was finally diagnosed as having G-CSF-producing epithelioid MPM at autopsy.</p>
</sec>
<sec id="section2-1066896911420257">
<title>Clinical Findings</title>
<p>A 54-year-old man noticed pain in his left chest and back in the mid-2000. He was admitted our hospital because of the increase of C-reactive protein (CRP) and left pleural effusion. He was treated with antibiotics and had no response. Hyaluronic acid titer in the effusion increased: 255 000 ng/mL and no particular finding was found cytologically. In the beginning of 2001, left pleural effusion accumulated again. Chest radiography and computed tomography scanning disclosed a left pleural effusion and diffuse pleural thickening with no apparent mass lesion in the left lung field. He underwent core needle biopsies twice from the pleural tumor under a video-assisted thoracoscopic surgery (the first and second biopsies). Laboratory findings were as follows: white blood cell (WBC) count, 64 200/µL; stab and segmented leukocyte, 96.0%; serum G-CSF titer, 136 pg/mL (normal range &lt;39 pg/mL), and CYFRA, 128 ng/mL (normal range &lt;3.5 ng/mL). He underwent chemotherapy: cisplatin, gemcitabine hydrochloride, and vinorelbine ditartrate; however, without any chemotherapeutic effect. He died 20 months after the initial symptoms appeared. An autopsy was conducted with his family’s consent about 1 hour after death.</p>
</sec>
<sec id="section3-1066896911420257">
<title>Pathological Findings</title>
<p>The first and second core needle biopsies from the pleural tumor were diagnosed as a nonspecific fibrous pleuritis with suspicion of MPM or PMAL, respectively, because the second specimen was small and fragile and neoplastic cells were negative for all markers for mesothelioma or adenocarcinoma. No asbestos bodies were observed in any sputum cytology and biopsy materials.</p>
<p>At autopsy, a visceral and parietal pleural tumor located around the left lung (1750 g, measuring 23.8 × 12.8 × 14.6 cm) was observed, which was whitish colored, firm, and showed multiple nodules with massive necrosis and hemorrhage. Partially direct invasion into the left lung was seen. The tumor proliferated in a papillary, solid alveolar, pseudo-alveolar, and comedo patterns by neoplastic cells (<xref ref-type="fig" rid="fig1-1066896911420257">Figure 1A</xref>). They had a swollen and irregularly shaped nucleus, thick nuclear membrane, prominent eosinophilic nucleoli, and eosinophilic cytoplasm. Abnormal mitotic cells were observed. They were positive for periodic acid-Schiff, calretinin (<xref ref-type="fig" rid="fig1-1066896911420257">Figure 1B</xref>), D2-40 (<xref ref-type="fig" rid="fig1-1066896911420257">Figure 1C</xref>), HBME-1, CK5/6, wide-spectrum keratin, vimentin, and G-CSF (<xref ref-type="fig" rid="fig1-1066896911420257">Figure 1D</xref>), and CK19 in their cytoplasm, and E-cadherin in their surface membrane, and negative for alcian blue, colloidal iron, CEA, Ber-EP4, MOC31, B72.3, WT1, thrombomodulin, and TTF-1. MIB1 index was &lt;1% and p53 index was &lt;0.1 %. He, therefore, was diagnosed with a G-CSF-producing epithelioid MPM. No asbestos bodies were observed. Thickening of the pericardium, left diaphragm, and esophagus by tumor infiltration was seen. Pericardial thickening enveloped the entire heart without adhesion. A fibrous wall thickening, 12 cm in length and 2 cm in depth, was observed in the middle to lower esophagus in a circumferential fashion showing direct invasion into the propria muscularis. Multiple submucosal nodules, up to 5 mm in diameter, were seen in the small intestine. Metastases to the left clavicle and paraesophageal lymph nodes were seen. Microscopically detectable multiple tiny, 1 to 4 mm in diameter, metastases were observed in lungs (right, 890 g), showing bronchioloalveolar carcinoma–like growth pattern by neoplastic cells that were also positive for similar mesothelioma markers to those of the main tumor. Systemic anemia, marked fibrin-thrombi in the right lung, hyperplastic bone marrow, and accumulation of yellowish clear effusion in the right pleural space (500 cm<sup>3</sup>) were seen. No inflammatory cell infiltration was observed in any systemic organs and the pleural tumor.</p>
<fig id="fig1-1066896911420257" position="float">
<label>Figure 1.</label>
<caption><p>Pleural tumor (T) proliferates in a papillary and solid alveolar patterns around the left lung (A, hematoxylin–eosin stain, 40×) and neoplastic cells are positive for calretinin (B, 200×), D2-40 (C, 400×), and granulocyte–colony stimulating factor (D, 400×) in their cytoplasm. (B), (C), and (D): immunostain</p></caption>
<graphic xlink:href="10.1177_1066896911420257-fig1.tif"/>
</fig>
</sec>
<sec id="section4-1066896911420257" sec-type="discussion">
<title>Discussion</title>
<p><xref ref-type="table" rid="table1-1066896911420257">Table 1</xref> shows a summary of the reported cases<sup><xref ref-type="bibr" rid="bibr4-1066896911420257">4</xref><xref ref-type="bibr" rid="bibr5-1066896911420257"/><xref ref-type="bibr" rid="bibr6-1066896911420257"/><xref ref-type="bibr" rid="bibr7-1066896911420257"/><xref ref-type="bibr" rid="bibr8-1066896911420257"/><xref ref-type="bibr" rid="bibr9-1066896911420257"/><xref ref-type="bibr" rid="bibr10-1066896911420257"/><xref ref-type="bibr" rid="bibr11-1066896911420257"/><xref ref-type="bibr" rid="bibr12-1066896911420257"/>-<xref ref-type="bibr" rid="bibr13-1066896911420257">13</xref></sup> with G-CSF-producing MM, including the present case. All were men aged between 45 and 76 years (mean = 59 years). Their WBC ranged from 21 300/µL to 147 000/µL with mature neutrophils of 71% to 96.2% and serum G-CSF titer of 36.0 to 217 pg/mL. All cases died 10 days to 20 months later. It was unclear why all cases were Japanese men.</p>
<table-wrap id="table1-1066896911420257" position="float">
<label>Table 1.</label>
<caption><p>Summary of the Reported Cases With Granulocyte–Colony Stimulating Factor (G-CSF)-Producing Malignant Mesothelioma, Including the Present Case</p></caption>
<graphic alternate-form-of="table1-1066896911420257" xlink:href="10.1177_1066896911420257-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="center"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th align="center" colspan="2">G-CSF</th>
<th align="center" colspan="2">Neoplastic Cells (IHC)</th>
<th/>
<th/>
</tr>
<tr>
<th align="left">Case</th>
<th align="center">Age (Years)/Gender</th>
<th align="center">Occupation</th>
<th align="center">Primay Lesion</th>
<th align="center">WBC (/µL)</th>
<th align="center">Neutrophil (%)</th>
<th align="center">Subtype</th>
<th align="center">Serum Titer (pg/mL)</th>
<th align="center">IHC (Tumor Cell)</th>
<th align="center">Mesothelial Markers</th>
<th align="center">Adenosarcoma Markers</th>
<th align="center">Survival</th>
<th align="center">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>45/male</td>
<td>Plasterer</td>
<td>Pl</td>
<td>51 000</td>
<td>93</td>
<td>Sarcomatoid</td>
<td>49.7</td>
<td>+</td>
<td>HA(+)</td>
<td/>
<td>4 wk</td>
<td>Rikimaru et al<sup><xref ref-type="bibr" rid="bibr4-1066896911420257">4</xref></sup></td>
</tr>
<tr>
<td>2</td>
<td>76/male</td>
<td/>
<td>RP</td>
<td>24 000</td>
<td>71</td>
<td>Biphasic</td>
<td>50</td>
<td>+</td>
<td>HA(+)</td>
<td>Ber-EP4 (−)</td>
<td>5 mo</td>
<td>Masuda et al<sup><xref ref-type="bibr" rid="bibr5-1066896911420257">5</xref></sup></td>
</tr>
<tr>
<td>3</td>
<td>61/male</td>
<td>No AE</td>
<td>Pl</td>
<td>21 300</td>
<td>93</td>
<td>Biphasic</td>
<td>67.2</td>
<td>+</td>
<td>TM(+)</td>
<td>CEA (−)</td>
<td>7 mo</td>
<td>Ohbayashi et al<sup><xref ref-type="bibr" rid="bibr6-1066896911420257">6</xref></sup></td>
</tr>
<tr>
<td>4</td>
<td>54/male</td>
<td/>
<td>PC</td>
<td>52 700</td>
<td>93</td>
<td>Biphasic</td>
<td>88</td>
<td>+</td>
<td/>
<td/>
<td>10 d</td>
<td>Horio et al<sup><xref ref-type="bibr" rid="bibr7-1066896911420257">7</xref></sup></td>
</tr>
<tr>
<td>5</td>
<td>48/male</td>
<td>Painter</td>
<td>Pl</td>
<td>33 100</td>
<td>85</td>
<td>Desmoplastic</td>
<td>138</td>
<td>+</td>
<td/>
<td/>
<td>4 mo</td>
<td>Kasuga et al<sup><xref ref-type="bibr" rid="bibr8-1066896911420257">8</xref></sup></td>
</tr>
<tr>
<td>6</td>
<td>65/male</td>
<td>No AE</td>
<td>Pl</td>
<td>53 600</td>
<td>93</td>
<td>Sarcomatoid</td>
<td>36.0</td>
<td>+</td>
<td>CAL(+), TM(+)</td>
<td>Ber-EP4(−), CEA(−)</td>
<td>19 mo</td>
<td>Yoshimoto et al<sup><xref ref-type="bibr" rid="bibr9-1066896911420257">9</xref></sup></td>
</tr>
<tr>
<td>7</td>
<td>70/male</td>
<td>No AE</td>
<td>Per</td>
<td>46 300</td>
<td>96</td>
<td>Deciduoid</td>
<td>147</td>
<td>+</td>
<td>CAL(+)</td>
<td/>
<td>12 mo</td>
<td>Kimura et al<sup><xref ref-type="bibr" rid="bibr10-1066896911420257">10</xref></sup></td>
</tr>
<tr>
<td>8</td>
<td>59/male</td>
<td>Carpenter</td>
<td>Pl</td>
<td>147 000</td>
<td>96.2</td>
<td>Sarcomatoid</td>
<td>77</td>
<td>+</td>
<td>HA(+)</td>
<td/>
<td>2 mo</td>
<td>Nishimura et al<sup><xref ref-type="bibr" rid="bibr11-1066896911420257">11</xref></sup></td>
</tr>
<tr>
<td>9</td>
<td>68/male</td>
<td>No AE</td>
<td>Pl</td>
<td>34 950</td>
<td/>
<td>Biphasic</td>
<td>217</td>
<td>−</td>
<td>HABP(+)</td>
<td/>
<td>3 mo</td>
<td>Inoue et al<sup><xref ref-type="bibr" rid="bibr12-1066896911420257">12</xref></sup></td>
</tr>
<tr>
<td>10</td>
<td>49/male</td>
<td>Mechanic</td>
<td>Pl</td>
<td>50 000</td>
<td>89.4</td>
<td>Biphasic</td>
<td>130</td>
<td>+</td>
<td/>
<td/>
<td>11 wk</td>
<td>Usami et al<sup><xref ref-type="bibr" rid="bibr13-1066896911420257">13</xref></sup></td>
</tr>
<tr>
<td>11</td>
<td>54/male</td>
<td>Carpenter</td>
<td>Pl</td>
<td>64 200</td>
<td>96</td>
<td>Epithelioid</td>
<td>136</td>
<td>+</td>
<td>CAL(+), D2-40(+), HBME-1(+), CK5/6(+)</td>
<td>Ber-EP4(−), CEA(−), B72.3(−), WT1(−), TM(−)</td>
<td>20 mo</td>
<td>This study</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1066896911420257">
<p>Abbreviations: G-CSF, granulocyte–colony stimulating factor; IHC, immunohistochemistry; AE, asbesto exposure; WBC, white blood cell count; Pl, pleura; RP, retroperitoneum; PC, pericardium; Per, peritoneum; HA, hyaluronic acid; TM, thrombomodulin; CEA, carcinoembryonic antigen; CAL, calretinin; HABP, hyaluronic acid binding protein.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The diagnostic difficulty in distinguishing between MPM and PMAL has been recognized. Special mesothelial markers have been introduced for the diagnosis of MPM, including calretinin, D2-40, CK5/6, thrombomodulin, HBME-1, B72.3, WT1, mesothelin, Cav-1, cadherins, and CD44. On the other hand, there are special markers for PMAL for differentiation from MPM: CEA, Ber-EP4, MOC-31, TTF-1, SPA, and napsin A. In the present case, neoplastic cells were positive for calretinin, D2-40, HBME-1, CK5/6, and E-cadherin but negative for thrombomodulin, B72.3, and WT1.</p>
<p>Inoue et al<sup><xref ref-type="bibr" rid="bibr12-1066896911420257">12</xref></sup> reported a case diagnosed as a MPM showing high serum G-CSF and CYFRA titers. Neoplastic cells were negative for G-CSF. In the present case, both serum G-CSF and CYFRA showed high titers, and neoplastic cells were positive for G-CSF. Yoshimoto et al<sup><xref ref-type="bibr" rid="bibr9-1066896911420257">9</xref></sup> reported a case with MPM whose neoplastic cells were positive for C-GSF, interleukin-1β (IL-1β), and IL-6 in the cytoplasm. Kimura et al<sup><xref ref-type="bibr" rid="bibr10-1066896911420257">10</xref></sup> reported a case with malignant peritoneal mesothelioma that produced G-CSF and IL-6 and whose neoplastic cells were positive for C-GSF and IL-6. Therefore, G-CSF-producing MM may produce several cytokines such as IL-1β, IL-6, and so on.</p>
<p>The diagnostic criteria for G-CSF-producing tumors are as follows: (<italic>a</italic>) prominent granulocytosis without any other evidence of infection, (<italic>b</italic>) high serum G-CSF titer, (<italic>c</italic>) a decrease in WBC count and a normal serum G-CSF titer after tumor resection, and (<italic>d</italic>) the demonstration of G-CSF activity in tumor specimens or tumor cell culture.<sup><xref ref-type="bibr" rid="bibr14-1066896911420257">14</xref></sup> In the present case, the marked granulocytosis, high serum G-CSF level, and the G-CSF expression by neoplastic cells were compatible with a G-CSF-producing tumor.</p>
</sec>
</body>
<back>
<ack><p>The authors thank Prof M. Nakamura (Department of Pathology, Tokai University School of Medicine, Isehara, Japan), Dr Y. Abe (National Kanagawa Hospital, Hatano, Kanagawa, Japan), Prof H. Kusama (Department of Pathology, Tokyo Medical College Kasumigaura Hospital, Ami, Ibaraki, Japan), and Dr A. Sudo (Department of the Fifth Internal Medicine, Tokyo Medical College Kasumigaura Hospital) for their kind consultation and advice.</p></ack>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interests with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896911420257">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oka</surname><given-names>K</given-names></name>
<name><surname>Otani</surname><given-names>S</given-names></name>
<name><surname>Yoshimura</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Mucin-negative pseudomesotheliomatous adenocarcinoma of the lung</article-title>. <source>Acta Oncol</source>. <year>1999</year>;<volume>38</volume>:<fpage>1119</fpage>-<lpage>1121</lpage>.</citation>
</ref>
<ref id="bibr2-1066896911420257">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Husain</surname><given-names>AN</given-names></name>
<name><surname>Kumar</surname><given-names>V</given-names></name>
</person-group>. <article-title>The lung</article-title>. In: <person-group person-group-type="editor">
<name><surname>Kumar</surname><given-names>V</given-names></name>
<name><surname>Abbas</surname><given-names>AK</given-names></name>
<name><surname>Fausto</surname><given-names>N</given-names></name>
</person-group>, eds. <source>Robbins and Cotran Pathologic Basis of Disease</source>. <edition>7th ed.</edition> <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Elsevier Saunders</publisher-name>; <volume>2005</volume>: <fpage>768</fpage>-<lpage>770</lpage>.</citation>
</ref>
<ref id="bibr3-1066896911420257">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanayama</surname><given-names>R</given-names></name>
<name><surname>Oka</surname><given-names>K</given-names></name>
<name><surname>Fukunaga</surname><given-names>M</given-names></name>
<name><surname>Okano</surname><given-names>M</given-names></name>
<name><surname>Hakozaki</surname><given-names>H</given-names></name>
</person-group>. <article-title>Spindle cell carcinoma arising in the pharynx with granulocytosis and high serum G-CSF titer: a case report</article-title>. <source>J Laryngol Otol</source>. <year>2007</year>;<volume>121</volume>:<fpage>597</fpage>-<lpage>600</lpage>.</citation>
</ref>
<ref id="bibr4-1066896911420257">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rikimaru</surname><given-names>T</given-names></name>
<name><surname>Ichikawa</surname><given-names>Y</given-names></name>
<name><surname>Ogawa</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Production of granulocyte colony-stimulating factor by malignant mesothelioma</article-title>. <source>Eur Respir J</source>. <year>1995</year>;<volume>8</volume>:<fpage>183</fpage>-<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr5-1066896911420257">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Masuda</surname><given-names>Y</given-names></name>
<name><surname>Kizaki</surname><given-names>M</given-names></name>
<name><surname>Ueno</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Chronic myelogenous leukemia (CML) associated with granulocyte colony- stimulating factor (G-CSF)-producing mesothelioma</article-title>. <source>Leukemia</source>. <year>1995</year>;<volume>9</volume>:<fpage>1591</fpage>-<lpage>1594</lpage>.</citation>
</ref>
<ref id="bibr6-1066896911420257">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohbayashi</surname><given-names>H</given-names></name>
<name><surname>Nosaka</surname><given-names>H</given-names></name>
<name><surname>Hirose</surname><given-names>K</given-names></name>
<name><surname>Yamase</surname><given-names>H</given-names></name>
<name><surname>Yamaki</surname><given-names>K</given-names></name>
<name><surname>Ito</surname><given-names>M</given-names></name>
</person-group>. <article-title>Granulocyte colony stimulating factor-producing diffuse malignant mesothelioma of pleura</article-title>. <source>Intern Med</source>. <year>1999</year>; <volume>38</volume>:<fpage>668</fpage>-<lpage>670</lpage>.</citation>
</ref>
<ref id="bibr7-1066896911420257">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Horio</surname><given-names>H</given-names></name>
<name><surname>Nomori</surname><given-names>H</given-names></name>
<name><surname>Morinaga</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Granulocyte colony-stimulating factor-producing primary pericardial mesothelioma</article-title>. <source>Hum Pathol</source>. <year>1999</year>;<volume>30</volume>:<fpage>718</fpage>-<lpage>720</lpage>.</citation>
</ref>
<ref id="bibr8-1066896911420257">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kasuga</surname><given-names>I</given-names></name>
<name><surname>Ishizuka</surname><given-names>S</given-names></name>
<name><surname>Minemura</surname><given-names>K</given-names></name>
<name><surname>Utsumi</surname><given-names>K</given-names></name>
<name><surname>Serizawa</surname><given-names>H</given-names></name>
<name><surname>Ohyashiki</surname><given-names>K</given-names></name>
</person-group>. <article-title>Malignant pleural mesothelioma produces functional granulocyte-colony stimulating factor</article-title>. <source>Chest</source>. <year>2001</year>;<volume>119</volume>:<fpage>981</fpage>-<lpage>983</lpage>.</citation>
</ref>
<ref id="bibr9-1066896911420257">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimoto</surname><given-names>A</given-names></name>
<name><surname>Kasahara</surname><given-names>K</given-names></name>
<name><surname>Saito</surname><given-names>K</given-names></name>
<name><surname>Fujimura</surname><given-names>M</given-names></name>
<name><surname>Nakao</surname><given-names>S</given-names></name>
</person-group>. <article-title>Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines</article-title>. <source>Int J Clin Oncol</source>. <year>2005</year>;<volume>10</volume>:<fpage>58</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr10-1066896911420257">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>N</given-names></name>
<name><surname>Ogasawara</surname><given-names>T</given-names></name>
<name><surname>Asonuma</surname><given-names>S</given-names></name>
<name><surname>Hama</surname><given-names>H</given-names></name>
<name><surname>Sawai</surname><given-names>T</given-names></name>
<name><surname>Toyota</surname><given-names>T</given-names></name>
</person-group>. <article-title>Granulocyte-colony stimulating factor- and interleukin 6-producing diffuse deciduoid peritoneal mesothelioma</article-title>. <source>Mod Pathol</source>. <year>2005</year>;<volume>18</volume>:<fpage>446</fpage>-<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr11-1066896911420257">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nishimura</surname><given-names>M</given-names></name>
<name><surname>Itoh</surname><given-names>K</given-names></name>
<name><surname>Ito</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Autocrine growth by granulocyte colony-stimulating factor in malignant mesothelioma</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>82</volume>:<fpage>1904</fpage>-<lpage>1906</lpage>.</citation>
</ref>
<ref id="bibr12-1066896911420257">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Inoue</surname><given-names>C</given-names></name>
<name><surname>Kato</surname><given-names>S</given-names></name>
<name><surname>Higuchi</surname><given-names>K</given-names></name>
<name><surname>Inoue</surname><given-names>H</given-names></name>
</person-group>. <article-title>A case of malignant pleural mesothelioma with elevation of G-CSF and CYFRA in the serum and pleural fluid [in Japanese]</article-title>. <source>Nihon Kokyuuki Gakkai Zasshi</source>. <year>2007</year>;<volume>45</volume>:<fpage>243</fpage>-<lpage>246</lpage>. (<comment>Abstract in English</comment>)</citation>
</ref>
<ref id="bibr13-1066896911420257">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Usami</surname><given-names>N</given-names></name>
<name><surname>Uchiyama</surname><given-names>M</given-names></name>
<name><surname>Kawaguchi</surname><given-names>K</given-names></name>
<name><surname>Yasuda</surname><given-names>A</given-names></name>
<name><surname>Ito</surname><given-names>S</given-names></name>
<name><surname>Yokoi</surname><given-names>K</given-names></name>
</person-group>. <article-title>Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma</article-title>. <source>J Thorac Oncol</source>. <year>2007</year>;<volume>2</volume>: <fpage>257</fpage>-<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr14-1066896911420257">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Asano</surname><given-names>S</given-names></name>
<name><surname>Urabe</surname><given-names>A</given-names></name>
<name><surname>Okabe</surname><given-names>T</given-names></name>
<name><surname>Sato</surname><given-names>N</given-names></name>
<name><surname>Kondo</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue</article-title>. <source>Blood</source>. <year>1977</year>;<volume>49</volume>:<fpage>845</fpage>-<lpage>852</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>